PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27278252-7	2016	However, treatment of tuberin-deficient cells with rapamycin showed significant decrease in protein expression of all Nox.	Sirolimus	51-60	TSC complex subunit 2	Rattus norvegicus	22-29	
18094073-7	2008	However, the re-expression of TSC2 or inhibition of mTOR/S6K1 with rapamycin (sirolimus) augmented antiproliferative effects of IFNbeta in LAM and TSC2-null ELT3 cells.	Sirolimus	78-87	TSC complex subunit 2	Rattus norvegicus	147-151	
27078846-8	2016	In addition, rapamycin in combination with celecoxib, a COX2 inhibitor, strongly inhibited Tsc2-deficient cell growth.	Sirolimus	13-22	TSC complex subunit 2	Rattus norvegicus	91-95	
16595860-2	2006	In addition, the role of rapamycin, an antagonist of the molecular target of rapamycin, in the morphological changes of spine caused by TSC2 silencing was investigated.	Sirolimus	25-34	TSC complex subunit 2	Rattus norvegicus	136-140	
16595860-7	2006	However, rapamycin treatment could reverse the effect of TSC2-RNAi on spine length but not on spine density.	Sirolimus	9-18	TSC complex subunit 2	Rattus norvegicus	57-61	
15557109-6	2005	Previous work has shown that a specific mTOR inhibitor, rapamycin, effectively down-regulated mTOR activity in renal tumors of Eker rats that carry a germline Tsc2 mutation.	Sirolimus	56-65	TSC complex subunit 2	Rattus norvegicus	159-163	
16322235-7	2005	Both baseline and PDGF-induced O2*- levels were significantly higher in TSC2-/- cells and were reduced by treatment with rapamycin and inhibitors of mitochondrial electron transport.	Sirolimus	121-130	TSC complex subunit 2	Rattus norvegicus	72-76	
15557109-10	2005	Rapamycin also resulted in a significant decrease in the size of the Tsc2-related renal tumors.	Sirolimus	0-9	TSC complex subunit 2	Rattus norvegicus	69-73